株式会社極東書店トップ > 商品一覧 > Vascular Disease, Alzheimer's Disease, and Mild Cognitive Impairment : Advancing an Integrated Approach.
商品詳細
Vascular Disease, Alzheimer's Disease, and Mild Cognitive Impairment : Advancing an Integrated Approach.
・ISBN 978-0-19-063423-0 hard US$ 135.00
¥31,630.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
お気に入り
★★★
電子版あり 大学・学術機関向け電子ブック(eBook)ISBN 978-0-19-063425-4
| 著者・編者 | Libon, David J. / Lamar, M. / Swenson, R. A. et al. (eds.), |
|---|---|
| 出版社 | (Oxford U. Pr., US) |
| 出版年月 | 2020 |
| ページ数 | 504 pp. |
| 言語 | ENG |
| ニュース番号 | <655-L3519 655-P6170> |
解説
Alzheimer's disease (AD) and vascular dementia (VaD) are commonly viewed as the first and second most common types of dementia, respectively. The traditional paradigm has been to view and treat each illness as a separate entity with a separate pathophysiology. However, clinical and pathological studies suggest that the boundary separating AD and VaD, as well as their mild cognitive impairment (MCI) analogs, is not well defined. Thus, there is increased interest in viewing these diseases along a spectrum because of the significant overlap in the characterization and diagnosis of AD, VaD, and MCI. The focus of this edited volume is to examine how AD and VaD, as well as their MCI analogs, are best viewed as a heterogeneous, intersecting, if not a continuous disease state rather than separate, distinct entities. This book examines this approach by providing empirically based evidence, reviews of the literature, and chapters by key leaders in the field and will be of interest to clinical neuropsychologists and anyone studying or treating dementia in its many forms.